Puma Biotechnology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:PBYI Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
12 Aug 24	SellUS$81,466	Michael Miller	Individual		23,358	US$3.49
17 Jul 24	SellUS$81,128	Alan Auerbach	Individual		21,920	US$3.70

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PBYI?
Owner Type	Number of Shares	Ownership Percentage
Hedge Funds	2,880,888	5.87%
VC/PE Firms	6,341,998	12.9%
Individual Insiders	7,418,861	15.1%
General Public	8,384,354	17.1%
Institutions	24,061,583	49%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.2%.

Top Shareholders

Top 25 shareholders own 74.49% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14%	Alan Auerbach	6,891,386	US$21.7m	0.7%	no data
7.8%	BlackRock, Inc.	3,827,223	US$12.1m	7.12%	no data
7.41%	The Vanguard Group, Inc.	3,636,191	US$11.5m	1.03%	no data
6.68%	Acorn Bioventures	3,279,440	US$10.3m	11.8%	15.77%
6.24%	Frazier Life Sciences Management, LP	3,062,558	US$9.6m	0%	0.35%
5.87%	Millennium Management LLC	2,880,888	US$9.1m	-8.91%	0.01%
4.01%	Acadian Asset Management LLC	1,968,999	US$6.2m	0.91%	0.01%
3.61%	Renaissance Technologies LLC	1,772,413	US$5.6m	1.11%	0.01%
2.63%	Eversept Partners, L.P.	1,293,257	US$4.1m	-2.65%	0.32%
2.56%	Athyrium Capital Management, LP	1,256,411	US$4.0m	0%	88.07%
1.87%	Geode Capital Management, LLC	917,367	US$2.9m	-3.45%	no data
1.78%	American Century Investment Management Inc	874,543	US$2.8m	18.4%	no data
1.41%	Dimensional Fund Advisors LP	692,792	US$2.2m	14.3%	no data
1.23%	State Street Global Advisors, Inc.	601,542	US$1.9m	17%	no data
1.21%	Kennedy Capital Management LLC	593,046	US$1.9m	0%	0.04%
0.92%	GlobeFlex Capital LP	452,606	US$1.4m	0%	0.1%
0.75%	Connor, Clark & Lunn Investment Management Ltd.	368,455	US$1.2m	3.93%	0.01%
0.65%	Northern Trust Global Investments	317,739	US$1.0m	202%	no data
0.63%	Winton Capital Group Limited	308,980	US$973.3k	2.79%	0.06%
0.59%	SEI Investments Company	288,482	US$908.7k	-0.36%	no data
0.57%	BNY Asset Management	277,703	US$874.8k	-10.1%	no data
0.56%	Morgan Stanley, Investment Banking and Brokerage Investments	275,496	US$867.8k	1.94%	no data
0.51%	Affinity Asset Advisors, LLC	250,000	US$787.5k	0%	0.13%
0.5%	Los Angeles Capital Management LLC	245,695	US$773.9k	98.2%	no data
0.47%	SEI Investments Management Corporation	231,701	US$729.9k	45.3%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/27 22:59
End of Day Share Price	2024/12/27 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Puma Biotechnology, Inc. is covered by 17 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Huidong Wang	Barclays
Geoffrey Meacham	BofA Global Research
Alethia Young	Cantor Fitzgerald & Co.